$599

Cytokinetics Shares Aficamten Data; FDA Launches Pilot One-Day Inspectional Assessments

Two cardiometabolic-related news items have been observed: Cytokinetics presented additional aficamten data (view press release), and FDA launched pilot one-day inspectional assessments (view FDA news release). Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Already a member? Log in here